Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness

OBJECTIVE: Cardiac diastolic dysfunction (DD) and arterial stiffness are early manifestations of obesity-associated prediabetes, and both serve as risk factors for the development of heart failure with preserved ejection fraction (HFpEF). Since the incidence of DD and arterial stiffness are increasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroor, Annayya R., Mummidi, Srinivas, Lopez-Alvarenga, Juan Carlos, Das, Nitin, Habibi, Javad, Jia, Guanghong, Lastra, Guido, Chandrasekar, Bysani, DeMarco, Vincent G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061206/
https://www.ncbi.nlm.nih.gov/pubmed/33882908
http://dx.doi.org/10.1186/s12933-021-01270-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061206/
https://www.ncbi.nlm.nih.gov/pubmed/33882908
http://dx.doi.org/10.1186/s12933-021-01270-1

Ejemplares similares